Form D Explorer

Inspect source fieldsReport a record issue

Form D — Renasant Bio, Inc.

0001231919-25-000109 · filed Jul 14, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$30,000,000
Reported amount sold
$30,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Renasant Bio, Inc.
CIK
2075979
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
2630 BANCROFT WAY #507
BERKELEY, California 94704
Phone
650-223-5603

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗